Multiple China-made COVID-19 Drugs Enter Clinical Trials

preview_player
Показать описание
Chinese drug researchers and developers have been looking for the right medicine to beat the COVID-19 as variants of the virus have emerged to challenge the vaccines' effects, and they have achieved major progress as multiple drug candidates have finished pre-clinical studies and are ready for clinical trials.

Welcome to subscribe us on:

Рекомендации по теме
Комментарии
Автор

from clinical trial to approval to production, minimum 10 months

mmore